JP2013542011A5 - - Google Patents

Download PDF

Info

Publication number
JP2013542011A5
JP2013542011A5 JP2013533983A JP2013533983A JP2013542011A5 JP 2013542011 A5 JP2013542011 A5 JP 2013542011A5 JP 2013533983 A JP2013533983 A JP 2013533983A JP 2013533983 A JP2013533983 A JP 2013533983A JP 2013542011 A5 JP2013542011 A5 JP 2013542011A5
Authority
JP
Japan
Prior art keywords
zone
physiological
drug
algorithm
normal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013533983A
Other languages
English (en)
Japanese (ja)
Other versions
JP6062859B2 (ja
JP2013542011A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/056022 external-priority patent/WO2012051344A2/en
Publication of JP2013542011A publication Critical patent/JP2013542011A/ja
Publication of JP2013542011A5 publication Critical patent/JP2013542011A5/ja
Application granted granted Critical
Publication of JP6062859B2 publication Critical patent/JP6062859B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013533983A 2010-10-12 2011-10-12 プログラム、コンピュータで読み取り可能な媒体、薬剤送達コントローラー及び方法 Active JP6062859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39239910P 2010-10-12 2010-10-12
US61/392,399 2010-10-12
PCT/US2011/056022 WO2012051344A2 (en) 2010-10-12 2011-10-12 Maintaining multiple defined physiological zones using model predictive control

Publications (3)

Publication Number Publication Date
JP2013542011A JP2013542011A (ja) 2013-11-21
JP2013542011A5 true JP2013542011A5 (enExample) 2014-11-27
JP6062859B2 JP6062859B2 (ja) 2017-01-18

Family

ID=45938960

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013533983A Active JP6062859B2 (ja) 2010-10-12 2011-10-12 プログラム、コンピュータで読み取り可能な媒体、薬剤送達コントローラー及び方法

Country Status (7)

Country Link
US (1) US9700708B2 (enExample)
EP (1) EP2628115B1 (enExample)
JP (1) JP6062859B2 (enExample)
CA (1) CA2816388C (enExample)
DK (1) DK2628115T3 (enExample)
ES (1) ES2544874T3 (enExample)
WO (1) WO2012051344A2 (enExample)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
EP3868284A1 (en) 2007-10-10 2021-08-25 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9757510B2 (en) 2012-06-29 2017-09-12 Animas Corporation Method and system to handle manual boluses or meal events for closed-loop controllers
US9486578B2 (en) * 2012-12-07 2016-11-08 Animas Corporation Method and system for tuning a closed-loop controller for an artificial pancreas
US9907909B2 (en) * 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
CA2897925C (en) * 2013-01-14 2017-05-30 The Regents Of The University Of California Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type 1 diabetes applications
US9517306B2 (en) 2013-03-15 2016-12-13 Animas Corporation Method and system for closed-loop control of an artificial pancreas
US9795737B2 (en) 2013-03-15 2017-10-24 Animas Corporation Method and system for closed-loop control of an artificial pancreas
EP2973095B1 (en) 2013-03-15 2018-05-09 Animas Corporation Insulin time-action model
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
US9474855B2 (en) 2013-10-04 2016-10-25 Animas Corporation Method and system for controlling a tuning factor due to sensor replacement for closed-loop controller in an artificial pancreas
US9861747B2 (en) 2013-12-05 2018-01-09 Lifescan, Inc. Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
AU2015301146B2 (en) * 2014-08-06 2020-06-25 Regents Of The University Of California Moving-horizon state-initializer for control applications
US10737024B2 (en) 2015-02-18 2020-08-11 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
WO2017123525A1 (en) 2016-01-13 2017-07-20 Bigfoot Biomedical, Inc. User interface for diabetes management system
US10610643B2 (en) 2016-01-14 2020-04-07 Bigfoot Biomedical, Inc. Occlusion resolution in medication delivery devices, systems, and methods
US10780223B2 (en) 2016-01-14 2020-09-22 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
FR3047098B1 (fr) * 2016-01-21 2018-05-25 Voluntis Gestion de l'equilibre glycemique d'un patient diabetique
JP6976957B2 (ja) * 2016-02-05 2021-12-08 アニマス エルエルシー 薬物送達システムのための可視化及び解析ツール
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
US10765807B2 (en) 2016-09-23 2020-09-08 Insulet Corporation Fluid delivery device with sensor
US11096624B2 (en) 2016-12-12 2021-08-24 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and systems
EP3568862B1 (en) 2017-01-13 2026-03-18 Insulet Corporation System and method for adjusting insulin delivery
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP3568860B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
WO2018132765A1 (en) 2017-01-13 2018-07-19 Mazlish Bryan Insulin delivery methods, systems and devices
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11497851B2 (en) 2017-03-31 2022-11-15 Lifescan Ip Holdings, Llc Maintaining maximum dosing limits for closed loop insulin management systems
US10729849B2 (en) 2017-04-07 2020-08-04 LifeSpan IP Holdings, LLC Insulin-on-board accounting in an artificial pancreas system
US11147920B2 (en) 2017-04-18 2021-10-19 Lifescan Ip Holdings, Llc Diabetes management system with automatic basal and manual bolus insulin control
CA3059985C (en) 2017-05-05 2023-08-08 Eli Lilly And Company Closed loop control of physiological glucose
EP3438858A1 (en) 2017-08-02 2019-02-06 Diabeloop Closed-loop blood glucose control systems and methods
CA3085930A1 (en) 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose
JP6938363B2 (ja) * 2017-12-27 2021-09-22 オムロンヘルスケア株式会社 情報処理装置、生体情報測定装置、方法及びプログラム
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11147919B2 (en) 2018-04-23 2021-10-19 Medtronic Minimed, Inc. Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system
US11158413B2 (en) * 2018-04-23 2021-10-26 Medtronic Minimed, Inc. Personalized closed loop medication delivery system that utilizes a digital twin of the patient
CN118750687A (zh) 2018-05-04 2024-10-11 英赛罗公司 基于控制算法的药物输送系统的安全约束
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
JP2021528758A (ja) 2018-06-22 2021-10-21 イーライ リリー アンド カンパニー インスリンとプラムリンタイドの送達システム、方法、およびデバイス
JP2022501139A (ja) 2018-09-28 2022-01-06 インスレット コーポレイション 人工膵臓システム用活動モード
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11986629B2 (en) * 2019-06-11 2024-05-21 Medtronic Minimed, Inc. Personalized closed loop optimization systems and methods
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
US11957875B2 (en) 2019-12-06 2024-04-16 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
JP7512395B2 (ja) 2020-01-06 2024-07-08 インスレット コーポレイション 持続する残差に基づく食事および/または運動行為の予測
EP4100958A1 (en) 2020-02-03 2022-12-14 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US12121700B2 (en) 2020-07-22 2024-10-22 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
US12128215B2 (en) 2020-09-30 2024-10-29 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
EP4221588A1 (en) 2020-09-30 2023-08-09 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
US12431229B2 (en) 2021-03-10 2025-09-30 Insulet Corporation Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
US12406760B2 (en) 2021-06-07 2025-09-02 Insulet Corporation Exercise safety prediction based on physiological conditions
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
EP4409581A1 (en) 2021-09-27 2024-08-07 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
EP4243030A1 (en) 2022-03-09 2023-09-13 Insulet Corporation Adjusting medicament delivery parameters in an open loop medicament delivery mode
CN120457493A (zh) 2023-01-06 2025-08-08 英赛罗公司 自动或手动启动的随餐推注输送及随后的自动安全约束放宽
US20250166810A1 (en) * 2023-11-22 2025-05-22 Cilag Gmbh International Data streams multi-system interaction

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3251224B2 (ja) * 1998-02-26 2002-01-28 勲 長澤 病棟情報システム
US8423113B2 (en) * 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US8369919B2 (en) * 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US9135402B2 (en) * 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
EP1881786B1 (en) * 2005-05-13 2017-11-15 Trustees of Boston University Fully automated control system for type 1 diabetes
US9392969B2 (en) * 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US8721584B2 (en) * 2006-11-02 2014-05-13 The University Of North Carolina At Chapel Hill Methods and systems for determining an intravenous insulin infusion rate to correct hyperglycemia of a patient, to maintain euglycemia of a patient, and to prevent hypoglycemia of a patient
US20080154513A1 (en) * 2006-12-21 2008-06-26 University Of Virginia Patent Foundation Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes
EP2139540A1 (en) * 2007-03-19 2010-01-06 Medingo Ltd. User interface for selecting bolus doses in a drug delivery device
US8221345B2 (en) * 2007-05-30 2012-07-17 Smiths Medical Asd, Inc. Insulin pump based expert system
WO2009139846A1 (en) * 2008-05-12 2009-11-19 Department Of Veterans Affairs Automated system and method for diabetes control
CN102405011A (zh) * 2008-11-26 2012-04-04 弗吉尼亚大学专利基金会 用于跟踪糖尿病中血糖变异性的方法、系统和计算机程序产品
EP2399205B1 (en) * 2009-02-25 2020-04-08 University Of Virginia Patent Foundation Cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery

Similar Documents

Publication Publication Date Title
CN108261591B (zh) 一种人工胰腺的闭环控制算法
JP7457072B2 (ja) 生理的グルコースの閉ループ制御
JP6062859B2 (ja) プログラム、コンピュータで読み取り可能な媒体、薬剤送達コントローラー及び方法
RU2016115709A (ru) Способ и система контроля коэффициента настройки в связи с заменой датчика для контроллера с обратной связью при искусственной поджелудочной железе
JP2016504119A5 (enExample)
US20240358919A1 (en) Integrated insulin delivery system having safety features to prevent hypoglycemia
JP2016506775A5 (enExample)
AU2025204268A1 (en) Operating multi-modal medicine delivery systems
JP6243546B2 (ja) 先行する期間に基づくオフライングルコースレベル制御
JP2024079701A5 (enExample)
CA2929950C (en) Glucose rate increase detector: a meal detection module for the health monitoring system
CN109804434A (zh) 用于自动缓解运动影响的输注系统和方法
JP2017523852A5 (enExample)
JP2017505695A5 (enExample)
JP2016529632A5 (enExample)
WO2015056259A1 (en) System and method for improved artificial pancreas management
JP2016527057A5 (enExample)
JP2024504276A5 (enExample)
WO2017123805A1 (en) Predictive control model for the artificial pancreas using past predictions
KR102543616B1 (ko) 상대적 혈액량에 기반한 투석용 기술
Jørgensen et al. An artificial pancreas based on simple control algorithms and physiological insight
US20230381413A1 (en) Time-segmented basal rate adaptation process
US20230218821A1 (en) Tdd tracking approaches for insulin delivery systems, methods, and devices
EP4154259A1 (en) Insulin delivery systems, methods, and devices
CN116020003B (zh) 闭环人工胰腺胰岛素输注控制系统